The Translation of HDL Science Master Class*



Wednesday, May 30 ● 8:00 a.m. - 5:00 p.m. ~ Thursday, May 31 ● 8:00 a.m. - Noon

$195 NLA Members, $395 Non-Members, Trainees N/A.

Overview

Core Faculty

Philip J. Barter, MD, PhD
Director
The Heart Research Institute
Sydney, Australia

H. Bryan Brewer, Jr. MD*
Director
Washington Cardiovascular Associates
Senior Research Consultant
MedStar Research Institute
Washington, DC

M. John Chapman, BS, PhD, DSc
Director
INSERM (Dyslipidemia and Atherosclerosis Research)
President European Atherosclerosis Society
Paris, France

Michael H. Davidson, MD, FNLA *
Clinical Professor
Director of Preventive Cardiology
Executive Medical Director Radiant Research
The University of Chicago Pritzker School of Medicine
Chicago, IL

Jay W. Heinecke, MD
Professor of Medicine
University of Washington
Seattle, WA

Daniel J. Rader, MD, FNLA*
Professor of Medicine
University of Pennsylvania
Philadelphia, PA

Robert S. Rosenson, MD, FNLA*
Professor of Medicine
Mount Sinai School of Medicine
Director of Cardiometabolic Disorders
Mount Sinai Heart
New York, NY

Ernst J. Schaefer, MD, FNLA*
Distinguished University Professor
Tufts University School of Medicine
Boston, MA

*Donates Diplomate, American Board of Clinical Lipidology

Designed for experienced lipidologists, lipid specialists and researchers, the NLA's new HDL Master Class brings together an internationally renowned faculty for an in-depth examination of the latest evidence and research on HDL metabolism, functionality, subfractions, drugs in development and more. Interact with HDL "Masters" at this 1.5-day course and immerse yourself in this emerging area of lipid science.

Course Curriculum

  • HDL Epidemiology and History of Development into a Therapeutic Target
  • HDL Metabolism from the Macrophage to the Intestines
  • Familial HDL Deficiency Disorders
  • Lifestyle Changes and HDL
  • The Molecular Dynamics of HDL as Cardiovascular Toxin
  • Measurement of HDL Subfractions and Function
  • HDL Proteomics and Lipidomics
  • The Link Between Triglyceride and HDL Metabolism
  • Therapeutic Targets to Modify HDL
  • Drug Therapy to Modulate HDL: Challenges and Opportunity


 
Who's Online Now (0)/ Home/ About Us/ Community/ Members/ Calendar/ Education/ Publications/ Contact Us

Copyright © 2010 National Lipid Association. All Rights Reserved.
Terms of Service